The Vanguard Health Care ETF (VHT) seeks to track the MSCI US Investable Market Health Care 25/50 Index, which measures the performance of U.S. healthcare companies including pharmaceuticals, biotechnology, medical devices, and healthcare services providers across all market capitalizations.
How It Works
VHT uses a passively managed, market-capitalization-weighted approach that mirrors its benchmark index. The fund holds healthcare stocks in proportion to their market value, with larger companies like Johnson & Johnson and UnitedHealth receiving higher allocations. Rebalancing occurs quarterly to maintain index alignment. The ETF typically holds 300-400 healthcare companies, providing comprehensive exposure to the entire U.S. healthcare sector from large pharmaceutical giants to smaller biotech firms.
Key Features
- Ultra-low 0.10% expense ratio makes it one of the most cost-effective ways to access diversified healthcare sector exposure
- Covers entire healthcare value chain from drug discovery and medical devices to insurance and healthcare services providers
- Strong defensive characteristics with consistent dividend income, as healthcare demand remains relatively stable during economic downturns
Risks
- This ETF can lose significant value when regulatory changes threaten drug pricing or healthcare policies, potentially declining 20-30% during major reform periods
- Concentrated sector exposure means poor performance in one healthcare subsector can drag down the entire fund significantly
- Healthcare stocks often underperform during economic expansions when investors favor more cyclical sectors, leading to prolonged periods of relative weakness
Who Should Own This
Best suited as a satellite holding (5-15% of portfolio) for investors with 3+ year time horizons seeking defensive sector exposure or healthcare thematic investing. Medium risk tolerance required due to regulatory and biotech volatility. Ideal for investors wanting steady dividend income with long-term growth potential from aging demographics.